We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.45 | 3.40 | 3.50 | 3.45 | 3.45 | 3.45 | 1,232,578 | 07:31:42 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Medical Laboratories | 0 | -2.37M | -0.0262 | -1.32 | 3.11M |
TIDMVAL
RNS Number : 0104B
ValiRx PLC
04 January 2018
TR-1: Standard form for notification of major holdings
Hot Features
Premium
NOTIFICATION OF MAJOR HOLDINGS
----------------------------------------------------------------------------------------------------
1a. Identity of the issuer ValiRx PLC
or the underlying issuer
of existing shares to which
voting rights are attached(ii)
:
------------------------------------------------- -------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
----------------------------------------------------------------------------------------------------
Non-UK issuer X
------------------------------------------------------------------------------------- -------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------------- -------------
An acquisition or disposal of financial instruments
------------------------------------------------------------------------------------- -------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- -------------
Other (please specify)(iii) :
------------------------------------------------------------------------------------- -------------
3. Details of person subject to the notification obligation(iv)
Name YA II CD, Ltd.
City and country of registered
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
----------------------------------------------------------------------------------------------------
Name Jarvis Investment Management
Ltd
------------------------------------------------- -------------------------------------------------
City and country of registered
office (if applicable)
------------------------------------------------- -------------------------------------------------
5. Date on which the threshold 29 December 2017
was crossed or reached(vi)
:
------------------------------------------------- -------------------------------------------------
6. Date on which issuer notified 3 January 2018
(DD/MM/YYYY):
------------------------------------------------- -------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
----------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
---------------------- ------------------------- ---------------- ---------------- -------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 6.99% 6.99% 399,062,717
---------------------- ------------------------- ---------------- ---------------- -------------
Position Less than Less than
of previous 3% 3%
notification
(if
applicable)
---------------------- ------------------------- ---------------- ---------------- -------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class/type Number of voting rights(ix) % of voting rights
of
shares
ISIN code
(if possible)
----------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
--------------------- --------------------- -------------- ------------------------------ ---------------
Ordinary Shares
(GB00BWWYSP41) 27,903,383 0 6.99% 0
---------------------- --------------------- -------------- ------------------------------ ---------------
SUBTOTAL 8.
A 27,903,383 6.99%
---------------------- ------------------------------------- -----------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
---------------------- --------------------- -------------- ------------------------------ ---------------
SUBTOTAL 8.
B 1
-------------- ------------------------------ ---------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
--------------------- ---------------------- -------------- ----------------- ----------- ---------------
SUBTOTAL
8.B.2
----------------- ----------- ---------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which X
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
----------------------------------------------------------------- ---------------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
--------------------- ----------------- ----------------------- ---------------------
Yorkville Advisors
Global II, LLC 6.99% 6.99%
--------------------- ----------------- ----------------------- ---------------------
Yorkville Advisors
Global, LP 6.99% 6.99%
--------------------- ----------------- ----------------------- ---------------------
YA II CD, Ltd. 6.99% 6.99%
--------------------- ----------------- ----------------------- ---------------------
10. In case of proxy voting, please identify:
---------------------------------------------------------------------------------------- Name of the proxy holder ---------------------------------------- ---------------------------------------------- The number and % of voting rights held ---------------------------------------- ---------------------------------------------- The date until which the voting rights will be held ---------------------------------------- ---------------------------------------------- 11. Additional information(xvi) ---------------------------------------------------------------------------------------- The Ordinary Shares are held by Jarvis Investment Management in CREST for the benefit of YA II CD, Ltd. The shareholder is the holder of Convertible Note Instrument dated 30 November 2016. The shareholder submitted conversion notices to the Issuer (the "Conversion Shares") for 17,130,106 Ordinary Shares on 29 November 2017, 20,349,169 Ordinary Shares on 6 December 2017, 10,285,760 Ordinary Shares on 8 December 2017, and 25,222,857 Ordinary Shares on 21 December 2017 totalling 72,987,892 Conversion Shares plus 2,680,526 shares already held by the shareholder which represented 18.96% of the aggregate voting rights of the Issuer. 47,765,035 of the Conversion Shares were sold by the shareholder to independent third parties between 30 November 2017 and 3 January 2018 (the "Trades"). The Conversion Shares were issued on 29 December 2017 and 3 January 2018 and were used to settle the Trades. Jarvis is currently long 27,903,383 shares of the Issuer as of 3 January 2018. This notification of major holdings is being filed in connection with the receipt and disposal of the Conversion Shares in connection with the Trades. ---------------------------------------------------------------------------------------- Place of completion Mountainside, New Jersey, USA -------------------- ------------------------------ Date of completion 3 January 2018 -------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUSUSRWNAARAR
(END) Dow Jones Newswires
January 04, 2018 09:29 ET (14:29 GMT)
1 Year Valirx Chart |
1 Month Valirx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
